Cargando…
Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19
Autores principales: | Vorobjeva, Nina V., Sud'ina, Galina F., Chernyak, Boris V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878366/ https://www.ncbi.nlm.nih.gov/pubmed/33584318 http://dx.doi.org/10.3389/fphar.2021.609508 |
Ejemplares similares
-
Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021) -
Role of Mitochondria in the Regulation of Effector Functions of Granulocytes
por: Vorobjeva, Nina V., et al.
Publicado: (2023) -
Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
por: Sud’ina, Galina F., et al.
Publicado: (2022) -
Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022) -
Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming
por: Golenkina, Ekaterina A., et al.
Publicado: (2022)